Published in Biochem Biophys Res Commun on February 28, 1994
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol (1995) 10.61
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A (2002) 4.46
The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest (2007) 3.76
Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest (2012) 2.58
Altered fracture repair in the absence of MMP9. Development (2003) 2.41
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration. Biomaterials (2010) 1.31
Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther (2010) 1.30
Role of hypoxia-inducible factor-1alpha in angiogenic-osteogenic coupling. J Mol Med (Berl) (2009) 1.20
Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia (2003) 1.17
Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis Model Mech (2010) 1.13
Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol (1997) 1.09
Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing. J Biol Chem (2007) 1.08
Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc Natl Acad Sci U S A (2010) 1.07
The dose of growth factors influences the synergistic effect of vascular endothelial growth factor on bone morphogenetic protein 4-induced ectopic bone formation. Tissue Eng Part A (2009) 1.07
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng Part A (2013) 0.99
Targeting polymer therapeutics to bone. Adv Drug Deliv Rev (2012) 0.98
Concave pit-containing scaffold surfaces improve stem cell-derived osteoblast performance and lead to significant bone tissue formation. PLoS One (2007) 0.95
Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential. Stem Cells Dev (2014) 0.89
Expression of the vascular endothelial growth factor receptor, KDR, in human placenta. J Anat (1996) 0.88
Effect of Local Sustainable Release of BMP2-VEGF from Nano-Cellulose Loaded in Sponge Biphasic Calcium Phosphate on Bone Regeneration. Tissue Eng Part A (2015) 0.83
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain. J Bone Miner Res (2016) 0.83
Experimental construction of BMP2 and VEGF gene modified tissue engineering bone in vitro. Int J Mol Sci (2011) 0.82
Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer. BMC Cancer (2014) 0.81
Adsorption of vascular endothelial growth factor to two different apatitic materials and its release. J Mater Sci Mater Med (2001) 0.80
Production of VEGF receptor 1 and 2 mRNA and protein during endochondral bone repair is differential and healing phase specific. J Appl Physiol (1985) (2010) 0.79
The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration. Biomed Res Int (2014) 0.78
The Difference between Growth Factor Expression after Single and Multiple Fractures: Preliminary Results in Human Fracture Healing. Dis Markers (2015) 0.77
The prolyl hydroxylase inhibitor dimethyloxalylglycine enhances dentin sialophoshoprotein expression through VEGF-induced Runx2 stabilization. PLoS One (2014) 0.76
Preclinical evaluation of sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases. BMC Cancer (2013) 0.75
Effects of TGF-β1 and VEGF-A transgenes on the osteogenic potential of bone marrow stromal cells in vitro and in vivo. J Tissue Eng (2012) 0.75
A review of computational models of bone fracture healing. Med Biol Eng Comput (2017) 0.75
RhoGTPase stimulation is associated with strontium chloride treatment to counter simulated microgravity-induced changes in multipotent cell commitment. NPJ Microgravity (2017) 0.75
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J (2000) 1.43
Erythroblasts are a source of angiogenic factors. Blood (2001) 1.17
Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol (1995) 1.10
Vascular endothelial growth factor is an autocrine growth factor for hair dermal papilla cells. J Invest Dermatol (1996) 1.08
Purification, characterization, and biological properties of the eye-derived growth factor from retina: analogies with brain-derived growth factor. J Neurosci Res (1982) 1.06
Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell (1991) 1.01
Signal relays in the VEGF system. Front Biosci (1999) 0.96
Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. Biochem Biophys Res Commun (1998) 0.95
Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype. Am J Pathol (1997) 0.92
Control of vascular endothelial growth factor angiogenic activity by the extracellular matrix. Biol Cell (1998) 0.91
Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor. J Biol Chem (1997) 0.89
Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells? Blood (1999) 0.89
Comparison of the effects of EGF, pFGF and EDGF on corneal epithelium wound healing. Curr Eye Res (1984) 0.82
Activation of Flk-1/KDR mediates angiogenesis but not hypotension. Cardiovasc Res (1997) 0.80
A highly reliable and sensitive assay for the purification of cellular growth factors. Cell Mol Biol (1984) 0.80
Adsorption of vascular endothelial growth factor to two different apatitic materials and its release. J Mater Sci Mater Med (2001) 0.80
Eye-derived growth factor from retina and epidermal growth factor are immunologically distinct and bind to different receptors on human foreskin fibroblasts. FEBS Lett (1982) 0.78
Relationship between structure and fatty acid metabolism in mitochondria isolated from ischemic rat hearts. Circ Res (1981) 0.77
Ovarian germinal epithelial cells respond to basic fibroblast growth factor and express its gene: implications for early folliculogenesis. Endocrinology (1989) 0.77
[Modulation of the tumoral progression by anti-idiotypic antibodies of angiogenesis factors]. C R Acad Sci III (1996) 0.76
Inhibition of basic fibroblast growth factor and vasculotropin biological activities on cultured cells by almitrine. Biochim Biophys Acta (1995) 0.76
[Tumoral vascularization: physiopathology and therapeutic prospects]. Bull Cancer (1997) 0.75
Biology and physiopathology of angiogenesis: the 1997 Philippe Laudat Conference. Angiogenesis (1998) 0.75
[Angiogenesis]. Pathol Biol (Paris) (1999) 0.75
Vascular endothelial cells: targets for studying the activity of hair follicle cell-produced VEGF. Cell Biol Toxicol (1996) 0.75